Total Payments
$16,190
2024 Payments
$2,392
Companies
27
Transactions
252
Medicare Patients
1,253
Medicare Billing
$121,890
Payment Breakdown by Category
Other$11,474 (70.9%)
Food & Beverage$4,456 (27.5%)
Education$259.87 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,474 | 45 | 70.9% |
| Food and Beverage | $4,456 | 193 | 27.5% |
| Education | $259.87 | 14 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $9,691 | 95 | $0 (2023) |
| ABBVIE INC. | $3,927 | 45 | $0 (2024) |
| Merz North America, Inc. | $448.74 | 5 | $0 (2023) |
| Janssen Biotech, Inc. | $360.48 | 16 | $0 (2024) |
| Lilly USA, LLC | $191.87 | 4 | $0 (2024) |
| Dermavant Sciences, Inc. | $188.50 | 11 | $0 (2024) |
| AMAG Pharmaceuticals, Inc. | $179.65 | 12 | $0 (2020) |
| PFIZER INC. | $146.32 | 7 | $0 (2024) |
| Amgen Inc. | $138.64 | 7 | $0 (2024) |
| Mission Pharmacal Company | $138.27 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,392 | 48 | ABBVIE INC. ($1,986) |
| 2023 | $2,967 | 37 | AbbVie Inc. ($1,940) |
| 2022 | $3,136 | 36 | Allergan, Inc. ($2,882) |
| 2021 | $5,243 | 40 | Allergan, Inc. ($5,096) |
| 2020 | $326.08 | 15 | Allergan, Inc. ($142.75) |
| 2019 | $815.12 | 24 | Allergan Inc. ($323.49) |
| 2018 | $695.83 | 25 | Allergan Inc. ($377.66) |
| 2017 | $614.42 | 27 | Allergan Inc. ($311.85) |
All Payment Transactions
252 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $180.00 | General |
| 11/21/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Inflammation | ||||||
| 11/15/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: DERMATOLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $61.75 | General |
| 11/04/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.59 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.59 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Inflammation & Immunology | ||||||
| 10/08/2024 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 10/04/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $16.25 | General |
| 09/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $23.00 | General |
| 09/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/31/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $2.56 | General |
| Category: DERMATOLOGY | ||||||
| 08/30/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: DERMATOLOGY | ||||||
| 08/29/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Dermatology | ||||||
| 08/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Immunology | ||||||
| 08/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.79 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $184.65 | General |
| 08/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/31/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: DERMATOLOGY | ||||||
| 07/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.42 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 374 | 711 | $113,864 | $38,416 |
| 2022 | 7 | 269 | 557 | $76,560 | $26,464 |
| 2021 | 10 | 367 | 664 | $105,300 | $36,080 |
| 2020 | 10 | 243 | 407 | $71,206 | $20,930 |
Total Patients
1,253
Total Services
2,339
Medicare Billing
$121,890
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 52 | 90 | $33,750 | $9,016 | 26.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 111 | $19,660 | $8,518 | 43.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 72 | 128 | $15,540 | $6,357 | 40.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 48 | 59 | $9,329 | $4,361 | 46.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 39 | 71 | $9,585 | $3,010 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 19 | $4,530 | $2,192 | 48.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $9,280 | $2,174 | 23.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $4,550 | $1,660 | 36.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 29 | 191 | $7,640 | $1,128 | 14.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 76 | $12,160 | $6,022 | 49.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 50 | 102 | $12,240 | $5,116 | 41.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 32 | 48 | $17,905 | $4,870 | 27.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 38 | 51 | $8,290 | $3,994 | 48.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 36 | 63 | $9,165 | $2,810 | 30.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 29 | 29 | $9,280 | $2,529 | 27.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 26 | 188 | $7,520 | $1,124 | 14.9% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 54 | 78 | $29,250 | $7,890 | 27.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 58 | 79 | $12,060 | $5,848 | 48.5% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 56 | 63 | $11,315 | $4,919 | 43.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 60 | 98 | $11,630 | $4,779 | 41.1% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 12 | 25 | $8,800 | $3,834 | 43.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 34 | 34 | $10,480 | $3,191 | 30.5% |
| 17000 | Destruction of skin growth | Office | 2021 | 34 | 62 | $8,670 | $2,636 | 30.4% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 30 | 191 | $7,640 | $1,169 | 15.3% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 18 | 23 | $2,255 | $1,119 | 49.6% |
About Dr. Ellen Burov, MD
Dr. Ellen Burov, MD is a Specialist healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528146958.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ellen Burov, MD has received a total of $16,190 in payments from pharmaceutical and medical device companies, with $2,392 received in 2024. These payments were reported across 252 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($11,474).
As a Medicare-enrolled provider, Burov has provided services to 1,253 Medicare beneficiaries, totaling 2,339 services with total Medicare billing of $121,890. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location New York, NY
- Active Since 11/02/2006
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1528146958
Products in Payments
- BOTOX (Biological) $717.53
- XEOMIN (Biological) $293.96
- BOTOX COSMETIC (Biological) $219.10
- REMICADE (Biological) $188.64
- VTAMA (Drug) $188.50
- TALTZ (Drug) $170.64
- INTRAROSA (Drug) $157.42
- TREMFYA (Drug) $155.81
- KYBELLA (Biological) $149.74
- Winlevi (Drug) $112.82
- EUCRISA (Drug) $109.25
- DIVIGEL (Drug) $92.92
- Balcoltra (Drug) $86.84
- CitraNatal (Drug) $86.65
- Otezla (Drug) $86.27
- RINVOQ (Biological) $79.31
- SKYRIZI (Biological) $77.99
- Prolia (Biological) $52.37
- CITRANATAL (Drug) $51.62
- JUBLIA (Drug) $46.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in New York
Dr. Eric Rose, M.d, M.D
Specialist — Payments: $4.9M
Specialist $4.9M
Dr. Baron Lonner, M.d, M.D
Specialist — Payments: $2.9M
Specialist $2.9M
Dr. Richard Spaide, Md, MD
Specialist — Payments: $1.7M
Specialist $1.7M
Dr. Marla Dubinsky, M.d, M.D
Specialist — Payments: $1.6M
Specialist $1.6M
Mrs. Naomi Nakao, M.d, M.D
Specialist — Payments: $1.1M
Specialist $1.1M
Dr. Janice Dutcher, M.d, M.D
Specialist — Payments: $994,054
Specialist $994,054